Page 39 - merged
P. 39
Index
Friday, 20 November
Session # Abstract Title
P2‐110 (AsCNP) The Relationships between Cortical Morphology Measures and Neuropsychological Tests in Chronic Kidney
Disease
Chao‐Wen Huang (Taiwan)
P2‐111 (AsCNP) Graph Theoretical Analysis of Abnormal Structural Networks in Major Depressive Disorder with Diffusion
Tensor MRI
Vincent Chin‐Hung Chen (Taiwan)
P2‐112 (AsCNP) Altered Cortical Gamma Responses to Faces in Unipolar and Bipolar Disorders: An MEG Study
Tai‐Ying Liu (Taiwan)
P2‐113 (AsCNP) Involvement of Cholinergic System in Hyperactivity in Dopamine Deficient Mice
Shinya Kasai (Japan)
P2‐114 (AsCNP) Low‐Dose Methylphenidate Monotherapy for Features of Attention‐Deficit/Hyperactivity Disorder
Secondary to Hereditary Cerebellar Ataxia
Li‐Yu Hu (Taiwan)
P2‐115 (AsCNP) Morphine Withdrawal Catatonia
Yi‐Shan Wu (Taiwan)
P2‐116 (AsCNP) Bilateral Atrophic Change of Insula in a Patient with Major Depressive Disorder and Chronic Insomnia
Chih‐Ming Cheng (Taiwan)
P2‐117 (WPAIC) Postpartum Depression of New Parents: A Longitudinal Study in Taiwan
Yen‐Chun Liu (Taiwan)
P2‐118 (WPAIC) Duration of Untreated Illness in Postnatal Depression: Early Data Regarding Impact on Clinical Course
Tze‐Ern Chua (Singapore)
P2‐119 (WPAIC) Paternal Anxiety and Depression among Fathers in Hong Kong and Its Relationship with Maternal Mental
Health and Paternal‐Infant Attachment
Antoinette Marie Lee (Hong Kong)
P2‐120 (WPAIC) Effects of Liquiritin on Body Weight and Food Intake in Rats Chronically Exposed to Stress
Zhi‐Yu Zhao (China)
P2‐121 (WPAIC) Significant Effect of Valproate Augmentation Therapy in Schizophrenic Patients: A Meta‐Analysis
Ping‐Tao Tseng (Taiwan)
P2‐122 (WPAIC) Protective Effect of Saikosaponin B2 on Damage of Cultured Sh‐Sy5Y Cells in Vitro Introduced by Hydrogen
Peroxide
Yan Zhang (China)
P2‐123 (WPAIC) The Effect of Xiao Huan Tang Combined Risperidone on the Open Field Behavior of Schizophrenic Mice
Model
Yan Zhang (China)
P2‐124 (WPAIC) The Differential Role of Cytokines for Clozapine Induced Fever
Tzu‐Yun Wang (Taiwan)
P2‐125 (WPAIC) A Randomized, Double‐Blind, Comparison of the Efficacy and Safety of Olanzapine Versus
Low‐Dose Olanzapine Plus Low‐Dose Trifluoperazine in the Treatment of Schizophrenia
Shih‐Chi Lin (Taiwan)
P2‐126 (WPAIC) The Efficacy of Vortioxetine in the Treatment of Patients with Mdd in Short‐Term
Placebo‐Controlled Studies: A Meta‐Analysis of 11 Studies
Pranab Kalita (Singapore)
P2‐127 (WPAIC) The Safety and Tolerability of Vortioxetine in Treating Adults with Major Depressive Disorder After 52
Weeks of Open‐Label Treatment
Pranab Kalita (Singapore)
-7-